The primary suppressors of the tumor immune system, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and PD-L1 immune checkpoints, can suppress T-cell cytokine production and proliferation [2]. The gene discussed is CD274; the disease is neoplasm.